4/A//SEC Filing
Graham G. Walmsley 4/A
Accession 0000935836-25-000323
CIK 0001750284other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 7:14 PM ET
Size
4.5 KB
Accession
0000935836-25-000323
Insider Transaction Report
Form 4/AAmended
Graham G. Walmsley
Director
Holdings
- 1,800,000(indirect: See note)
Common Stock
Footnotes (1)
- [F1]These securities are held by Logos Global Master Fund LP ("Logos Master Fund"). This holding was inadvertently omitted from the Form 4 filed by the reporting person on December 17, 2024. Logos Master Fund did not participate in the transactions reported in that Form 4. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001777517
Filing Metadata
- Form type
- 4/A
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 7:14 PM ET
- Size
- 4.5 KB